On Friday 30 October 2026, the Swedish market will close at 13:00 CET. Denmark and Norway will be open as usual.

SelectImmune Pharma AB (publ)

SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes

Board

CEO

  • Gabriela Godaly (tf)

Chairperson of the Board

  • Catharina Svanborg

Board

  • Carl-Johan Wachtmeister
  • Gabriela Godaly
  • Helena Lomberg
*Powered by Modular Finance